期刊文献+

过氧化氢在门静脉高压症大鼠侧支循环建立中的作用 被引量:3

Role of hydrogen peroxide in the formation of portosystemic collaterals in portal hypertension
下载PDF
导出
摘要 目的探讨过氧化氢(H2O2)对胆总管结扎诱导的肝硬化门静脉高压症(PHT)大鼠门体侧支循环形成的影响机制。方法胆总管结扎诱导的肝硬化PHT大鼠和假手术组大鼠每天一次腹腔分别注射浓度为10 000 U/kg聚乙二醇过氧化氢酶(PEG-catalase)或生理盐水,共8 d。测定大鼠肠系膜组织H2O2含量,利用彩色微球技术测定门体分流率及相应血流动力学指标。检测大鼠肠系膜组织中血管内皮生长因子(VEGF)及VEGF受体-2(VEGFR-2)蛋白含量。结果肝硬化PHT组大鼠门静脉压力、肠系膜组织H2O2水平及门体分流程度明显高于对照组大鼠。PEG-catalase处理使PHT大鼠门体分流率明显下降,VEGF及VEGFR-2蛋白水平明显降低,内脏高血流动力循环得到明显改善。结论 H2O2在肝硬化PHT内脏高动力循环形成过程中发挥重要作用,这和VEGF介导的血管增生有关。 Objective To explore the role of hydrogen peroxide(H2O2) in the formation of portosystemic collaterals in portal hypertensive(PHT) rats. Methods The bile duct ligation-induced cirrhotic rats and normal rats were treated with polyethylene glycol-catalase(PEG-catalase, 10 000 U/d/kg, ip.) or saline for 8 d. Then the hemodynamic studies were performed using the colored microsphere technique. Protein expressions of vascular endothelial growth factor(VEGF) were determined by Western blotting. The H2O2 level of mesentery was measured with the Hydrogen Peroxide Assay Kit. Results Compared with sham-operated animals, the portal pressure,the production of H2O2 and the formation of portal-systemic collateral vessels were higher in portal hypertensive rats. PEG-catalase administration resulted in a significant decrease in portal-systemic collaterals and a lower expression of VEGF in PHT rats. Conclusion H2O2 plays an important role in the development of the splanchnic hyperdynamic circulation in experimental portal hypertension syndrome, which is associated with VEGF-induced angiogenesis.
出处 《肝胆胰外科杂志》 CAS 2015年第1期22-25,共4页 Journal of Hepatopancreatobiliary Surgery
基金 国家自然科学基金项目(81370548)
关键词 血管增生 过氧化氢 聚乙二醇过氧化氢酶 高血压 门静脉 血管内皮生长因子 大鼠 angiogenesis hydrogen peroxide polyethylene glycol-catalase portal hypertension vascular endothelial growth factor rats
  • 相关文献

参考文献11

  • 1Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule [J]. Hepatology, 2006, 43(2 Suppl 1): S121-131.
  • 2Fernandez M, Vizzutti F, Garcia-Pagan JC, et al. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic col- lateral vessel formation in portal hypertensive mice [J]. Gastroenterology, 2004, 126(3): 886-894.
  • 3Fernandez M, Mejias M, Angermayr B, et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats [J]. J Hepatol, 2005, 43(1): 98-103.
  • 4Oshikawa J, Urao N, Kim HW, et al. Extracellular SOD-derived H202 promotes VEGF signaling in caveolae/lipid rafts and post- ischemic angiogenesis in mice [J]. PLoS One, 2010, 5(4): e10189.
  • 5Chen W, Liu DJ, Huo YM, et al. Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension [J]. Int J Biol Sci, 2014, 10(4): 386-395.
  • 6Angermayr B, Fernandez M, Mejias M, et al. NAD(P)H oxi- dase modulates angiogenesis and the development of port- osystemic collaterals and splanchnic hyperaemia in portal hy- pertensive rats [J]. Gut, 2007, 56(4): 560-564.
  • 7Woolley JF, Stanicka J, Cotter TG. Recent advances in reactive oxygen species measurement in biological systems [J]. Trends Biochem Sci, 2013, 38(11): 556-565.
  • 8Burgoyne JR, Oka S, Ale-Agha N, et al. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system [J]. Antioxid Redox Signal, 2013, 18(9): 1042-1052.
  • 9Sousa T, Oliveira S, Afonso J, et al. Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II [J]. Br J Pharmacol, 2012, 166(8): 2386-2401.
  • 10Beckman JS, Minor RL Jr, White CW, et al. Superoxide dismutase and catalase conjugated to polyethylene glycol increases en- dothelial enzyme activity and oxidant resistance [J]. J Biol Chem, 1988, 263(14): 6884-6892.

二级参考文献12

  • 1杨建芬,吴性江,曹建民,韩建明,黎介寿.生长抑素对门静脉高压症患者门静脉血流动力学的影响[J].中华实验外科杂志,2004,21(7):869-870. 被引量:3
  • 2潘峥,吴性江,李为苏,徐旻,黄传鼎,黎介寿.犬肝硬化模型形成中肝功能性血流量的变化[J].中华实验外科杂志,2005,22(11):1405-1405. 被引量:3
  • 3Varela JE,Cohn SM,Giannotti GD,et al.Near-infrared spectroscopy reflects changes in mesenteric and systemic perfusion during abdominal compartment syndrome.Surgery,2001,129:363-370.
  • 4Hakkinen JP,Miller MW,Smith AH,et al.Measurement of organ blood flow with coloured microspheres in the rat.Cardiovasc Res,1995,29:74-79.
  • 5Iwamaru A,Watanabe M,Yu S,et al.Measurement of tumor blood flow using colored dye extraction microspheres in two rat tumor models.Int J Oncol,2001,18:227-232.
  • 6Prinzen FW,Bassingthwaighte JB.Blood flow distributions by microsphere deposition methods.Cardiovasc Bes,2000,45:13-21.
  • 7Heymann MA,Payne BD,Hoffman JI,et al.Blood flow measurements with mdionuclide-labeled particles.Prog Cardiovasc Dis,1977,20:55-79.
  • 8Vorobioff J,Bredfeldt JE,Groszmann RJ.Increased blood flow through the portal system in cirrhotic rats.Gastroenterology,1984,87:1120-1126.
  • 9Kowallik P,Schulz R,Guth BD,et al.Measurement of regional myocardial blood flow with multiple colored microsphcres.Circulation,1991,83:974-982.
  • 10Hale SL,Alker KJ,Kloner RA.Evaluation of nonradioactive,colored microspheres for measurement of regional myocardial blood flow in dogs.Circulation,1988,78:428-434.

共引文献2

同被引文献36

  • 1MARUYAMA H, YOKOSUKA O. Pathophysiology of portal hypertension and esophageal varices [J]. Int J Hepatol, 2012, 2012: 895787-895787.
  • 2LEE G-H, BHANDARY B, LEE E-M, et al. The roles of er stress and p450 2el in ccl4-induced steatosis [J]. Int J Biochem Cell Biol, 2011, 43(10): 1469-1482.
  • 3PANIGRAHY D, KALISH B T, HUANG S, et al. Epoxyeico- sanoids promote organ and tissue regeneration [J]. P Natl Acad Sci USA, 2013, 110(33): 13528-13533.
  • 4CHEN W, LIU D-J, HUO Y-M, et al. Reactive oxygen species are involved in regulating hypocontractility of mesenteric ar- tery to norepinephrine in cirrhotic rats with portal hyperten- sion [J]. Int J Biol Sci, 2014, 10(4): 386-395.
  • 5QIN J, SUN D, JIANG H, et al. Inhibition of soluble epox- ide hydrolase increases coronary perfusion in mice [J]. Physiol Rep, 2015, 3(6), pil: e12427.
  • 6KISSELEVA T, BRENNER D A. Mechanisms of fibrogenesis [J]. Exp Biol Med, 2008, 233(2): 109-122.
  • 7ANGERMAYR B, MEJIAS M, GRACIA-SANCHO J, et al. Heme oxygenase attenuates oxidative stress and inflamma- tion, and increases vegf expression in portal hypertensive rats [J]. J Hepatol, 2006, 44(6): 1033-1039.
  • 8STABLES M J, GILROY D W. Old and new generation lipid mediators in acute inflammation and resolution [J]. Prog Lipid Res, 2011, 50(1): 35-51.
  • 9SIRISH P, LI N, LIU J-Y, et al. Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhib- itors in the prevention of cardiac fibrosis [J]. Proc Natl Acad Sci USA, 2013, 110(14): 5618-5623.
  • 10BOSCH J, GARCiA-PAGAN J C. Complications of cirrhosis and portal hypertension [J]. J Hepatol, 2000, 32(I Suppl): 141-156.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部